Algert Global LLC Uro Gen Pharma Ltd. Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.12 - $8.74 $972 - $1,660	-190 Reduced 1.8%	10,350 $85,000
Q1 2022 May 16, 2022	BUY	$5.92 - $9.73 $62,396 - $102,554	10,540 New	10,540 $92,000
Q2 2021 Aug 13, 2021	SELL	$15.2 - $20.94 $176,776 - $243,532	-11,630 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$17.99 - $26.96 $209,223 - $313,544	11,630 New	11,630 $227,000
Q3 2020 Nov 16, 2020	SELL	$18.81 - $26.42 $204,652 - $287,449	-10,880 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$16.5 - $29.7 $179,520 - $323,136	10,880 New	10,880 $284,000

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.